Market Research Blog

Oral rinse or mouthwash, as commonly known, is liquids used to support dental hygiene. Sometimes also referred to as mouth bath or mouth rinse, oral rinse is used complimentary to the conventional dental health and hygiene products like toothbrush, dental floss among others.

Oral rinse could be a part of regular dental care routine or could be dentist prescribed for the treatment of particular dental condition like plaque, inflammation, fungal infection. Some oral rinse products are also used as saliva substitute in dry mouth condition called xerostomia to neutralize the acid formation.

Another category of oral rinse is cosmetic oral rinse which specifically target bad breath problems.

It is unlikely for COVID-19 to have an impact on the oral rinse market directly. However, disruptions in the supply chain like delay in procurement, movement restrictions in various parts of the globe due to uneven lockdown periods, will be encountered. Protection protocols like social distancing will affect the distribution channel as people are most likely to avoid visiting stores and purchase the oral rinse products using online resources.

The drivers for the growth of the global oral rinse market are many. Various efforts like campaigning by dentists and leading market players have led to increasing awareness among people for dental hygiene and health which is the most significant driver for the growth of the global oral rinse market.

Another driver for the global oral rinse market could be increasing per capita income of people which they invest in wellness products like mouthwash. Increasing number of people suffering from bad breath condition will also result in pushing the global oral rinse market.

Rising completion coupled with introduction of innovative products is set to give momentum to the global oral rinse market. Patients’ convenience while using the product will swing the global oral rinse market positively by increasing the adoptability of oral rinse.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12794

Nonetheless, the global oral rinse market has certain barriers which could dampen the growth curve. With many players in the global oral rinse market the pricing has become increasingly competitive and this consequently can hinder the market momentum.

Lack of awareness in the developing coupled with low spending capacity of people in these regions can be one of the barriers in the global oral rinse market.

According to the statistics provided by the Centre for Disease Control and Prevention, more than 90% of the population of the USA is expected to have dental caries. Based on indication type, antiseptic segment of the global oral rinse market is poised to register attractive growth since it is the most commonly used type of oral rinse care product.

Based on product type, therapeutic segment is estimated to be growing fastest segment in the global oral rinse market owing to the increasing incidences of dental health issues around the globe.

Based on the distribution channel, retail pharmacies can be expected to be the most lucrative segment in the global oral rinse market owing to maximum patient footfall.

The global oral rinse market is expected to be dominated by North America and Europe in the forecast period based on the higher degree of awareness in these regions coupled with higher per capita income of the populations.

The developing regions of Africa, South Asia and East Asia can be considered lucrative emergent markets for the global oral rinse market as there is a growing awareness for dental care and hygiene together with steadily rising disposable incomes in these regions. Middle East could be an attractive market in the global oral rinse market if alcohol free mouthwash is introduced in the region.

Major players operating the global oral rinse market are

• Proctor & Gamble
• Johnson & Johnson
• GlaxoSmithKline
• Unilever
• Colgate-Pamolive
• Lion
• Amway
• Dendron
• Himalaya
• Desert Essence
• Weleda

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-12794

The report covers exhaustive analysis on:

• Oral rinse Market Segments
• Oral rinse Market Dynamics
• Historical Actual Market Size 2015 – 2019
• Oral rinse Market Size & Forecast 2020 to 2030
• Market Current Trends/Issues/Challenges
• Competition & Companies involved
• Market Drivers and Restraints

Regional analysis includes

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Report Highlights:

• Shifting Industry dynamics
• In-depth market segmentation
• Historical current and projected industry size recent industry trends
• Key Competition landscape
• Strategies for key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance

Key Segments

The global oral rinse market is segmented based on the indication type, product type, distribution channel and region.

Indication type:

• Antiseptic
• Analgesic
• Anti-fungal
• Anti-inflammatory

Product type:

• Cosmetic
• Therapeutic

Distribution channel:

• Online Pharmacies
• Drug Store
• Dental Dispensaries
• Retail Pharmacies

Nasal vaccines are the administration of mucosal vaccines through nasal route using a nasal sprayer or intra-nasal drop.  Mucosal infections are caused by several groups of bacteria and viruses.

Mucosal immunization is advantageous than the conventional administration routes due to the induction of both systemic and mucosal immune responses, additional pathogen protection by mucosal secretory IgA antibodies at entry site and its non-invasive nature.

According to the Forum of International Respiratory Societies, lower respiratory tract infection and pneumonia claim 4 million lives every year. World Health Organization (WHO) stated, over 3 to 5 million hospitalized and 0.2 million deaths reported due to influenza.

Nasal vaccines, due to their non-invasiveness, easy access and better immunization are emerging as viable administration alternate to oral or intramuscular administrations. Nasal vaccines may confer protection to the mucosa of lungs, genital tract and intestines.

The global nasal vaccines market is lucrative and is anticipated to register to boost growth with the progressing R&D, Coronavirus emergence, past paced clinical trials and increasing prevalence of other respiratory infections.

Surging cases of respiratory infections such as Streptococcus, Enterobacteriaceae, and viral such as Haemophilus influenza, Coronavirus, Adenovirus and others are propelling the nasal vaccines market growth. Also, the advantageous properties of nasal vaccines, increased compliance, key players and R&D progress are promoting the market growth.

Nasal vaccines emerges as a viable vaccine delivery alternate due to its non-invasiveness, better absorption in microvilli surface, protection from infection at entry site and elicits both mucosal systemic immune response. Drug manufacturers are working with the novel strategy of nasal vaccines development including live-attenuated-pathogen, adjuvants, nanoparticles, mucoadhesives, viruses-like-particles, DNA-vaccines and lipid-based-particulates.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12784

However several challenges constraints the nasal vaccines market growth such as restricted delivery volume (up-to 25 to 200 microlitre), limited efficacy and altered drug permeability due to mucociliary activities, poor antigen retention, limited compatible adjuvants, adverse reactions including mild fever and ache.

Nasal vaccines application does not apply to infants and allergic patients. Nasal vaccines delivery strategies require more research for better administration and to broaden disease coverage. The additional cost of nasal vaccines delivery devices and regulatory obligations hamper the nasal vaccines market growth, with the major challenge of implementing in vivo data into clinical results.

Although the overall global nasal vaccines market is poised to grow with the increasing compliance of nasal vaccines, improving design strategies, healthcare delivery settings, looming prevalence of respiratory disease and pandemic threat pushing the market for massive vaccination objectives.

Several efficient and safer co-adjuvants have been developed such as ChiSys® for norovirus. Also, emerging nasal vaccines such as FluMist Quadrivalent, NanoStat, Nasovac™ and many others, are fuelling the market.

The global nasal vaccines market is anticipated to grow with the looming viral pandemic and respiratory infections and high acceptance of nasal vaccines. By type, COVID-19 vaccines dominate the segment of nasal vaccines types due to its massive R&D, fast-paced clinical trials to curb the global infections and deaths.

By applications, children lead the nasal vaccines application segment due to the high efficacy. Immunose™ FLU approved for influenza for children and FluMist nasal spray is more effective in children than adults. By dosage form, nasal spray vaccine dominates the nasal vaccines market with the giant market of influenza, Alzheimer’s disease, swine flu and adenovirus, also the rigorous R&D for COVID-19 vaccine development have a deliberated focus on nasal spray vaccines.

Europe holds the largest global nasal vaccines market due to their advanced nasal vaccine delivery systems, high compliance, surging tolls of COVID-19 and other respiratory infections and government support. Europe has experienced diverse COVID-19 outbreaks, along with the increased investment into nasal vaccines R&D for COVID-19.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-12784

Asia-pacific region holds the significant global nasal vaccines market with the fastest growth attributed by the rigorous R&D, regional market players, the active collaboration of government and drug manufacturers to develop a vaccine for threatening viral pandemic, COVID-19 and others respiratory infections.

Nasal spray vaccines are under the prime focus for COVID-19 vaccine in China and India. North America nasal vaccine market is growing with active contribution from Canada having vast acceptance, advanced R&D and healthcare infrastructure of nasal vaccines.

Latin America nasal vaccines market is supported by the elevating research and clinical developments of nasal vaccines for influenza and COVID-19. MEA & Africa region has a stagnant nasal vaccines market due to the poor healthcare and research facilities, however nasal vaccine market growth is expected to elevate by the advancing research and healthcare of Israel and South-Africa.

The key players of nasal vaccines market include

• Sanofi
• AstraZeneca
• Abbott
• GlaxoSmithKline
• Serum Institute of India
• Bharat Biotech
• Antares Pharma
• INJEX Pharma GmbH
• BioDiem
• PharmaJet and Crossject

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Historical Actual Market Size, 2015 – 2019
• Market Size & Forecast 2020 to 2030
• Market Current Trends/Issues/Challenges
• Competition & Companies involved
• Market Drivers and Restraints

Regional analysis includes

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Report Highlights:

• Shifting Industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size recent industry trends
• Key Competition landscape
• Strategies for key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance

Key Segments

The global nasal vaccines market is segmented into types, applications, dosage form and regions.

Types :

• Flu Vaccines
• COVID-19 Vaccines
• Other Vaccines

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/12784

Applications :

• Adult
• Children

Dosage form :

• Adult
• Children

According to a recently released intelligence study by Future Market Insights (FMI), the neurosurgery surgical power tools market currently sits in a slow-moving growth-low value quadrant. As per the market assessment for a period of 2018-2028, the valuation of neurosurgery surgical power tools market will be over a billion dollar in 2023 and is likely to expand at a relatively moderate growth rate over the next three years.

The global burden of neurological disorders as a leading cause of death and disability has doubled in the recent years given the increasing number of older people, with potential contribution from longer disease duration. Environmental factors apart from demographic factors could further aggravate the future burden of neurological disorders, globally. Given the operative complexities associated with neurosurgeries, apart from orthopedic, cardiovascular, spine, and ENT surgeries, power tools are the current key advanced product in the medical devices industry, showing promising results due to its applicability in a number of procedures ranging from wound management to cutting/incision, drilling, removal and sawing of both hard and soft tissues and bone.

Prominently operated by Colgate-Palmolive Company, Glaxo Smith Kline plc, Johnson & Johnson, P&G, Unilever plc, and Dentsply Sirona, the dental hygiene devices landscape is currently witnessing dominance of toothbrush sales. In recent years, the dramatic growth of the E-commerce sector is translating into elevating online sales of dental hygiene devices, which is posing strong competition facing the retail pharmacy segment.

Toothbrush Records Highest Sale, Online Retail Firms up

A recent market research study by Future Market Insights provides exclusive insights on the current and prospective performance of global dental hygiene devices market, in terms of sales volume as well as revenue.

“The report categorizes dental hygiene devices landscape into the toothbrush, scalers, polishing devices, and others on the basis of product type. Toothbrush has been the top-selling product in global dental hygiene devices landscape, attributed to widespread availability, extensive selection range, broad price range, and frequent innovation,” explains a senior research analyst at FMI.

Currently, toothbrush sales account for almost 60% of the total market revenue, whereas the report indicates that dental scalers and dental polishing devices are gradually gaining ground. The study projects over 5% year over year revenue growth for the latter two in 2019 and ahead.

Retail pharmacies will remain the largest revenue generating channel of distribution in dental hygiene devices market. Whereas, online pharmacies are slated to present promising investment opportunities to dental hygiene devices manufacturers. The report projects that revenue generated through online retail would cross the US$ 1 billion mark in the next 3-4 years.

To remain ‘ahead’ of your competitors, request for a sample 

Key Dynamics Prompt at Rising Oral Care Concerns

The global dental hygiene devices market is low-value high-volume landscape, which remains the key factor that dampens investment. While baby boomers have been referred to as the primary consumers of dental hygiene devices, a growing percentage of juvenile and millennial people afflicted with one or more oral health problems points to the widening prospects of dental hygiene devices in coming years.

Increasing dental disease prevalence, coupled with the increasingly sophisticating infrastructure of dental care across developing regions, is predominantly responsible for improving the scope of dental hygiene devices penetration. Dental caries, periodontal conditions, and oral cancer mark some of the most significant concerns related to oral healthcare, among the population.

Key Players :

• Colgate-Palmolive Company
• The Procter & Gamble Company
• Koninklijke Philips N.V.
• Unilever plc.
• Glaxosmithkline plc
• Ultradent Products Inc.
• Johnson & Johnson
• 3M Company
• Dabur India Ltd.
• Dentsply Sirona.

Asian Economies Create an Attractive Investment Pocket

The report sheds light on all the aspects related to worldwide demand for dental hygiene devices and offers insights on the growth prospects projected for global dental hygiene devices market through the next few years. The report forecasts steady yet moderate yearly revenue growth of 4.7% in 2019, and around 1/3rd of the total market value is poised to be accounted for by the Asia Pacific. North America and Western Europe are likely to hold a collective share of more than a third of the global market value.

APAC and Latin America are poised to remain highly lucrative regional markets for manufacturers of dental hygiene devices owing to consistently increasing demand for dental treatments in these regions.

Although the widening patient pool is driving the steady demand for dental hygiene devices, a sizeable population based in developing countries is still undiagnosed and untreated. FMI research points to the presence of several untapped opportunities in a massive untreated population and thereby highlights high attractiveness of emerging regional markets for dental hygiene devices manufacturers.

Besides frequent product innovations, key players in the global dental hygiene devices market maintain their strategic focus on the enhancement of distribution channel by strengthening existing marketing efforts across Asian markets, particularly in India, Singapore, and Malaysia.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8177

Toothpaste Innovations Account for a Trending Wave

The report suggests that strategic collaborations, new product launches, and geographical expansion remain the highlights of developmental strategies adopted by key companies operating in dental hygiene devices landscape. Electric/battery-operated toothbrush innovations continue to shape new launch strategies of a majority of companies, whereas most of the market leaders are focusing on introducing novel toothpaste ranges specific to various oral care demands.

GSK recently unveiled a range of Aquafresh Advance specifically for 9-12 years olds’ demographic, targeting enamel protection and cavity prevention. The company’s Consumer Healthcare arm also launched a new Sensodyne Rapid Relief range in the US. P&G also released a new toothpaste range recently, specifically for improved gum health. Dabur India Ltd. launched a modern variant of their flagship toothpaste range i.e. ayurvedic specialist toothpaste in gel format.

For in-depth competitive analysis Buy Now – https://www.futuremarketinsights.com/checkout/8177

Segmentation

The report offers a comprehensive taxonomy of dental hygiene devices market based on product type, distribution channels and region.

The product type segment of the dental hygiene devices market includes tooth brush, dental polishing devices, dental scalers and other dental devices. The distribution channel segment of the dental hygiene devices market includes hospital pharmacies, retail pharmacies, and online pharmacies. The dental hygiene devices market has been analyzed across regions of North America, Latin America, Europe, Asia Pacific and MEA.

The research intelligence report offers a deep-dive view of the global hydrocephalus shunt market—predicted to expand at a rather sluggish rate of 2.3 percent, reaching a valuation of US$ 498.6 Million in 2020.

Future Market Insights foresees significant growth opportunities in hydrocephalus shunt market, considering the new-age development of smart shunt technology, while delivering advance diagnosis of cerebrospinal fluid (CSF), control, and communication, on the basis of sensors, telemetry, and feedback controls. Increasing focus on developing such smart shunt technology, is anticipated to prove favorable for the hydrocephalus shunt market—showcasing an otherwise sluggish landscape through the forecast period of 2018-2028, as per FMI’s analysis.

To remain ‘ahead’ of your competitors, request for a sample 

“Stringent regulatory policies is a key factor severely impacting the growth of hydrocephalus shunt market. In addition, mechanical risks including leaks, migration, obstruction, and discontinuity and biological complications including infection, abscess, pseudocyst, heamotoma, and peritonitis associated with shunt implants, is also a key factor contributing to the market’s slow-moving growth. Other contributing factors could include high surgery costs and shortage of trained neurologist—specifically reported in countries like Australia, Canada, Ireland, U.K, and New”, explains a senior analyst from the Healthcare domain. The analyst further explains that shunt blockage and malfunction are two common complication associated with stunt implants—blockages occurring in nearly 31 percent patients. Moreover, such risks and complications often result in a number of hydrocephalus shunt revision surgeries, further creating a notable demand for hydrocephalus shunt.

Competitive Landscape

This section of the report features profiles of the key players operating in the hydrocephalus shunt market based on their market shares, differential strategies, product offerings, marketing approach, and company dashboard. Examples of some of the key players featured in this report include

• Medtronic Plc.
• Braun Melsungen AG
• Integra LifeSciences Corporation
• Natus Medical Incorporated
• Tokibo Co., Ltd. (Sophysa SA)
• Christoph Miethke GmbH & Co. KG

Many companies in the hydrocephalus shunt market are aiming on development of smart shunt technology and to gain FDA approvals. The manufacture are mainly focusing on acquisition and collaboration activities to expand their product portfolio in the hydrocephalus shunt market. Since 1999, Aesculap division of B. Braun Melsungen AG and Christoph Miethke GmbH & Co. KG have been working together to develop and sale hydrocephalus shunts.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-7756

FMI offers key insights on the global hydrocephalus shunt market

Hydrocephalus valves segment is expected to hold a massive value share of nearly 85 percent.

Within the Hydrocephalus valves type, adjustable pressure valves is likely to witness maximum adoption in hydrocephalus shunt surgeries.

Highest growth potential exists in North America, with an attractiveness index of 2.6 during the forecast period. Such adoption trend is expected to be followed in Western Europe—the second most lucrative market, showcasing interesting profit possibilities.

By age group, pediatrics and infants segment will report maximum adoption of hydrocephalus shunt.

Ventriculoperitoneal will remain the most preferred procedure, pushing maximum revenue in the global hydrocephalus shunt.

Key Market Influencers: Technological Advancements and Awareness Campaigns for Hydrocephalus

Considering the complexity of hydrocephalus shunting along with adjustments of cerebrospinal fluid draining, manufacturers of hydrocephalus shunts are increasingly introducing programmable and anti-siphon shunt valves—aimed at regulating drainage pressure and flow. The new technologies are indicated to eliminate the need for surgery revisions as a result of complications. The cerebrospinal fluid management technologies are likely to witness increased adoption in the coming years considering its utility in reducing siphon effect over cerebrospinal fluid drainage. Programmable pressure valves are gaining prominence versus fix pressure valves owing to its external features using specialized magnetic devices that helps in modifying opening pressure of valves.

Additionally, demand for hydrocephalus shunts is slated to increase given the increasing number of government and private initiatives to spread awareness vis-à-vis hydrocephalus. Hydrocephalus Association, for instance, and its focus to conduct more hydrocephalus awareness campaigns and programs, with increased investments in research initiatives targeted at improving cure and treatment avenues for Hydrocephalus. Through its campaign ‘Roadmap to a Cure’, the organization, by 2020 is expected to invest US$20 and drive more research and support associated with hydrocephalus.

In the highly consolidated hydrocephalus shunt market,

product and pricing power lies in the hand of top three players—reigning over nearly 84 percent of the total revenue share in the global hydrocephalus shunt market. Contributing nearly US$ 389 Million, the top three players include Medtronic Plc., Integra LifeSciences Corporation, and B. Braun Melsungen AG. Key forward market strategies include- viz. Efforts to gain regulatory approvals, geographic expansions in emerging economies, production capacity expansion, increased investments in R&D, and acquisitions to solidify global position in neurosurgery and regenerative technologies. Strategic collaborations in the form of mergers and acquisitions, is expected to bring significant growth opportunities for the three leading players, predicts FMI in its hydrocephalus shunt market report.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-7756

Segmentation

The report offers a comprehensive taxonomy of the hydrocephalus shunt market based on product type, procedure type, age group and region. By product type, the hydrocephalus shunt market is segmented into hydrocephalus valves and hydrocephalus catheters. Hydrocephalus valve segment is further sub-segmented into fix pressure valves and adjustable pressure valves. Hydrocephalus catheters segment is further sub-segmented into standard catheters and antimicrobial catheters.

By procedure type, the hydrocephalus shunt market is segmented into

• ventriculoperitoneal
• ventriculoatrial
• lumboperitoneal
• ventriculopleural.

By age group, the hydrocephalus shunt market is segmented into pediatric and adult segment.

The hydrocephalus shunt market has been analyzed across eight regions including

• North America,
• Latin America,
• Europe,
• Asia Pacific Excluding China & Japan,
• China,
• Japan, and MEA.

According to the latest research by Future Market Insights (FMI), the global market for medical physics will exceed the valuation of US$ 6 billion towards the end of projection period.

Prominently driven by the growth of medical tourism sector and increasing expanse of diagnostics, the global revenue of medical physics market will reportedly thrive at a healthy over-6% CAGR during 2018-2028. Growing adoption of nuclear medicine has also been cited as an important factor responsible for a positive growth outlook anticipated for medical physics market.

However, the report also highlights that the insufficient availability of skilled workers and relatively poor healthcare infrastructure for medical physicist trainings in developing regional markets will continue to restrict penetration of medical physics in the long run.

“To remain ‘ahead’ of your competitors, request for a sample” https://www.futuremarketinsights.com/reports/sample/rep-gb-5274

The ‘Outsourcing’ Trend Is Creating Firm Base for Merger & Acquisition Strategies

With the consolidation of hospitals, there is an increasing need for larger firms in the medical physics market, with an intent to handle the outsourced services so as to contract with fewer services providers. The medical physics market is characterised by the presence of small independent companies, and there is a negligible number of large-scale operators. According to the report, this presents opportunities for private equity firms to enter the middle-market platform and scale-up their medium-scale operations to large-scale operations through the acquisition of smaller firms.

Other factors driving mergers and acquisitions in the medical physics market include increasing stringent regulations and an increasing number of owners looking to exit the medical physics business. Increasing stringent regulations have resulted in the inspection of a larger number of machines and associated elements. Several healthcare systems are incurring higher risks due to the increasingly stringent regulations. This opens opportunities for medical physics companies to ensure compliance and reduce operation cost by outsourcing. Furthermore, most of the medical physics firms are owned and operated by baby boomers who are about to retire from their medical physics business. For a majority of those medical physics service providers who are retiring, selling their business has been considered to be the most preferred option.

Some of the other trends in the medical physics market include increased outsourcing by healthcare providers, increasing number of independent diagnostic imaging centres, and advancements & adoption of technology across the world.
Segmental Insights: Medical Physics Market

Diagnostic modality, driven by increasing adoption of diagnostic procedures such as PET, SPECT, CT, and MRI, will continue to account for more than 65% share of the total medical physics market value.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-5274

Based on services, accreditation assistance is slated to remain dominant, followed by safety surveys. The report anticipates physics testing and regulatory and auditing services to emerge highly potential.

Following hospitals, diagnostic imaging centers are likely to register significant adoption rate in the medical physics market through 2027.

The North American and European medical physics market will reportedly account for a majority of market value, according to FMI’s analysis on medical physics market. The report has attributed this dominance to rapid consolidation of healthcare facilities in these regions.

Some of the key players in the medical physics market include Krueger-Gilbert Health Physics, Inc., LANDAUER, Medical Physics Services, Medical Physics Services Consultants, Inc., Alyzen Medical Physics Services, Radiation Safety & Control Services, Inc., Upstate Medical Physics Services, Dade Moeller & Associates, Versant Medical Physics Services & Radiation Safety, Alliance Medical Physics Services LLC, West Physics Consulting, LLC, Associates in Medical Physics Services, Radiation Services, Inc., Jaeger Corporation, and Petrone Associates, LLC.

Additional information on global medical physics market can be availed. Write to the analyst at press@futuremarketinsights.com

Global Medical Physics Market: Segmentation
Analysis by Modality

Diagnostic
Radiographic X-Ray Systems
Fluoroscopic X-Ray Systems
Dental X-Ray Systems
Mammography Systems
Computed Tomography
Magnetic Resonance Imaging
Ultrasound
SPECT
PET
Others
Therapeutic
LINAC
Brachytherapy
Others
Analysis by Service

Accreditation Assistance
Performance Testing
Physics Testing
Radiation Dose Monitoring
Radiation Safety Training
Treatment Commissioning Services
Safety Surveys
Regulatory and Auditing Services
Others
Analysis by End User

Hospitals
Ambulatory Surgical Centers
Diagnostic Imaging Centers
Academic and Research Institutes

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-5274
Analysis by Region

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa

Skin perfusion pressure (SPP) assess the local pressure in the microcirculatory system. It is widely used parameter in assessment of wound healing potential in patients with limb ischemia and peripheral artery diseases. SPP testing devices have become crucial for wound healing in patients with chronic limb ischemia. Future Market Insights (FMI), in a new study has forecast the market for skin perfusion pressure testing devices to exhibit 4.6% Y-o-Y growth in 2021. Driven by rising healthcare spending, the market will continue exhibiting high demand through the forecast period, from 2020 to 2030.

Key Companies Profiled

Vasamed Incorporated
Moor Instruments
Perimed AB
ELCAT GmbH
ATYS Medical
Viasonix
Promed Group

“To remain ‘ahead’ of your competitors, request for a sample” -https://www.futuremarketinsights.com/reports/sample/rep-gb-9263

Compared to other non-invasive methods such as toe blood pressure and ankle-brachial index, SPP provides more accurate results, and thus, its usage is gaining popularity among physicians. It has been observed that SPP can evaluate ischemic condition of the lower extremities which cannot be assessed by ankle-brachial index. This increases the preference of SPP over ABI, which in turn is expected to drive the skin perfusion pressure testing devices market.

The rising prevalence of peripheral arterial disease is another major factor driving the demand growth. Peripheral arterial disease (PAD) prevents wound healing of lower extremity. The patient populations at highest-risk have ischemic disease, foot ulcers, diabetes mellitus, and/or compromised kidney function. The most widely used test is ankle brachial index (ABI), but it has limited utility in foot ulcer patients. Ankle brachial index alone is not considered effective of wound healing. For overcoming this problem, manufacturers are focusing to develop advanced skin perfusion pressure.

The COVID-19 pandemic has significantly affected the medical practices, resulting in a decrease in non-essential medical care, including the wound healing specialty. The nationwide lockdown and disrupted supply chain has limited the ability to practice wound healing in normal conditions. The pandemic in the first few months of 2020 has had a negative impact on the skin perfusion pressure testing devices market.

Manufacturers are currently focusing on designing new innovative laser dopplers that can provide better results at less cost, and at the same time give simple and reliable outputs. For instance, free flap monitoring, a new generation device provides web-based capability, whereby, recordings from a laser doppler can be transmitted directly to a smart phone. Such advancements are expected to bode well for the global market.
Key Takeaways from Skin Perfusion Pressure Testing Devices Marker Study
The global skin perfusion pressure testing devices market is estimated to be US$ 28.83 Mn in 2020, is expected to grow at a market CAGR of 4.5% during the forecast period (2020-2030)
The U.S. holds over 90% share of the North America market, but Canada is projected to expand faster at around 5.0% CAGR
Germany holds the largest share of the market in Europe, and will expand at a CAGR of around 4.8% through 2030
The U.K. will exhibit 5.3% Y-o-Y growth in 2021, emerging as a key market for SPP testing devices in Europe. France will also continue exhibiting high demand
Japan and South Korea are expected to emerge as key markets for SPP testing devices in East Asia

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-9263

Skin Perfusion Pressure Testing Devices Market by Category
Product

Laser Doppler Skin Perfusion Pressure Testing Devices
Photoplethysmography Skin Perfusion Pressure Testing Devices
Consumables
Pressure Cuff Controller
Fibre Optic Probe
Modality

Portable Devices
Cart-based Devices
End User

Hospitals
Ambulatory Surgical Centers
Wound Care Centers
Vascular Laboratories
Region

North America
Latin America
Europe
East Asia
South Asia
Middle East and Africa (MEA)
Oceania
For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-9263

Western blotting, being the gold standard and confirmatory test for HIV diagnosis, is gaining traction around the world. As the increase in applications in diverse fields such as agriculture, diagnostics, life science research, to name a few, tends to persist, manufacturers operating in this industry are getting more inclined to bring in wider variety of products. The updated edition of Future Market Insights’ study tracks growth in over 20+ markets, covering the regulatory framework as well as strategies of leading players.

Tech advances in wearable devices and the rising consumer demand for health and fitness solutions are positively influencing manufacturers in the healthcare industry to develop smart devices such as biosensors, insulin pumps and more. According to Future Market Insights (FMI), the demand for wearable medical devices will rise owing to the growing global incidences of chronic ailments. The market is anticipated to reflect a promising rate of growth with approximately 7% CAGR through the end of the forecast period in 2031.

FMI, an ESOMAR-certified market research firm, states that the global hospital capacity management solutions market will reach US$ 994 Mn in 2020, growing at 5% y-o-y in 2020.